Figure 1From: Comparative evaluation of the effects of treatment with tocilizumab and TNF-α inhibitors on serum hepcidin, anemia response and disease activity in rheumatoid arthritis patientsCorrelation of serum hepcidin 25 levels with serum ferritin, C-reactive protein, vascular endothelial growth factor and disease activity score in 28 joints in rheumatoid arthritis patients. Baseline values showed a significant correlation between hepcidin-25 (Hepc-25) and (A) ferritin, (B) C-reactive protein (CRP), (C) vascular endothelial growth factor (VEGF) and (D) Disease Activity Score in 28 joints (DAS28).Back to article page